MedPath

A comparison of Mirena use in women with and without fibroids - Mirena and Fibroids

Conditions
Menorrhagia
Therapeutic area: Body processes [G] - Physiological processes [G07]
Registration Number
EUCTR2011-001461-40-GB
Lead Sponsor
Hull and East Yorkshire Acute Hospitals NHS Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

All women who have chosen and who have been fitted with a Mirena IUS as a way of controlling their heavy periods and who have asked to be included in the study.
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 200
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range 0

Exclusion Criteria

Any woman unwilling to attend for blood samples and vaginal ultrasound scans.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: We wish to establish whether women who require treatment for their heavy periods respond as favourably to the use of a Mirena IUS whether they have fibroids or not.;Secondary Objective: We wish to establish whether a Mirena IUS causes a reduction in the size of uterine fibroids;Primary end point(s): Bloodloss as determined by pictorial bloodloss assessment charts (PBAC)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath